Skip to main content
HOPA Abstracts, Adverse Events, Chemotherapy
Evaluation of Treatment Abandonment and Delay with Anticancer Agents at an Outpatient Community Hospital Cancer Center Oral Chemotherapy Clinic: A Retrospective Cohort Analysis
Abstract #PM01
Read More
HOPA Abstracts, Adverse Events
Evaluation of the Relationship between Hypoalbuminemia and Oral Anticancer Drug-Related Adverse Events in Adults with Solid Tumor Malignancies
Abstract #CT14
Read More
HOPA Abstracts, Multiple Myeloma, Vaccinations
Worldwide Influenza and Pneumococcal Vaccination Rates in Patients with Multiple Myeloma, and the Impact of Vaccination on Infection, Hospitalization, and Death
Abstract #CT13
Read More
HOPA Abstracts, Leukemia, Thromboembolism
The Incidence of Arterial and Venous Thromboembolism in Patients with Chronic Myeloid Leukemia or Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia Who Are Treated with Ponatinib
Abstract #CT12
Read More
HOPA Abstracts
Welcome to the First Annual Issue of HOPA Abstracts, 2021
Scott A. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Read More
HOPA Abstracts, Leukemia, Lymphoma
Results from informCLL, a Prospective Observational Registry: Prognostic Biomarker Testing, Treatment Patterns, and Dosing in 1461 Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Abstract #CT10
Read More
HOPA Abstracts, Myelofibrosis
Real-World Dosing Patterns of Ruxolitinib Among Patients with Myelofibrosis: A US Community Oncology Practice
Abstract #CT09
Read More
HOPA Abstracts, Multiple Myeloma
In-Class Transition from Parenteral Bortezomib to Oral Ixazomib in Newly Diagnosed Multiple Myeloma: Updated Real-World Results from the Community-Based US MM-6 Study
Abstract #CT08
Read More
HOPA Abstracts, Adverse Events, Leukemia
Incidence of Adverse Effects in Patients with Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia in Lymphoid Blast Crisis Receiving Ponatinib with or without Concomitant Azole Antifungals
Abstract #CT07
Read More
HOPA Abstracts, Colorectal Cancer
Encorafenib plus Cetuximab, with or without Binimetinib, for BRAF V600E–Positive Metastatic Colorectal Cancer: Relationship Between Carcinoembryonic Antigen and Clinical Outcomes from BEACON CRC
Abstract #CT06
Read More
Page 93 of 198
Results 921 - 930 of 1973